Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Eligible age
35–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD). This study is testing the health of the blood vessels and the activity of the nerves that control the blood vessels in adults with insulin resistance. The extent to which ascorbic acid (Vitamin C) improves the function of the blood vessels will be determined. The primary outcome is blood pressure, which is the result of blood vessel health and activity of the nerves, and the reduction in blood pressure that is observed with ascorbic acid.
Sponsor: University of Kansas Medical Center
You may qualify if…
- ✓ 1. Obese: BMI \>30 m/kg2
- ✓ 2. Middle-aged: 35-65 years
- ✓ 3. Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior.
- ✓ 4. Able and willing to provide written informed consent
You may not qualify if…
- ✕ 1. Diabetes mellitus: fasting glucose \< 1267 mg/dL and/or HbA1c \< 6.5%
- ✕ 2. Currently taking a statin or antihypertension medication
- ✕ 3. Hyperlipidemia: Fasting triglycerides \< 250 mg/dL
- ✕ 4. Hypertension: \<130/80 mmHg
- ✕ 5. History of heart disease (e.g., myocardial infarction, stent)
- ✕ 6. History of vascular disease (e.g., bypass, stroke)
Where it's recruiting
Kansas City
Source: ClinicalTrials.gov · NCT04715022 · last updated 2025-06-08